Objectives: This study was designed to investigate whether immunomodulation and Microglia polarization is involved in the anti-inflammatory and neuroprotective effect induced by hypoxic preconditioning (HPC) in the middle cerebral artery occlusion (MCAO) brain injury model. Methods: Longa method, (neurological disability status scale) NDSS method and TTC staining were used to evaluate the degree of cerebral infarction injury under different treatments (Sham, HPC, MCAO and co-treatment with HPC and MCAO). Western blot was used to detect expression profiles of apoptosis and related factors of neurological function. Flow cytometry was performed to analyze changes in the ratio of helper T cells, toxic T cells and NK cells in peripheral immune cells. And immunohistochemistry was used to examine the changes in microglial morphology. ELISA was used to evaluate the levels of nerve growth factors and neurogenesis conditions. Finally, RT-PCR was determined to analyze the transformation of microglia phenotype after HPC and MCAO treatment. Results: MCAO dramatically induced local formation of cerebral infarction. HPC relieved MCAO-induced cerebral infarction and increased rat cognition. HPC affected activation of microglia without significantly affecting in peripheral immune cell populations. After HPC co-treatment with MCAO, the M1 phenotype of microglia was changed and there was a transformation to M2. Conclusion: The treatment of HPC remarkably affected the polarization of microglia cells in MCAO rats, and reduced the cerebral nerve injury and played a protective role in MCAO model.
Introduction
In currently, stroke is the fourth modality of death in the world and causes irreversible nerve damage or permanent disability (Esenwa and Gutierrez, 2015; Fonseca and Ferro, 2015; Rodgers, 2013) . Recently, research focus on the nerve injury cascade induced by ischemic brain injury in the acute phase. Many neuroprotective compounds have been found in animal models of cerebral artery occlusion, but the clinical effects after transformation are not ideal (Gurgul et al., 2018; Hao, Chen, Yao, and Liu, 2018; Xi, Wang, Long, and Ma, 2018) . Researches have shown that multiple mechanisms involved in cranial nerve injury and renovate in the ischemic penumbra (Heit, Zaharchuk, and Wintermark, 2018; Horvath et al., 2018; Tauchi et al., 2018) . Peripheral or central embolism of blood vessels lead to ischemic brain injury, blood supply to the central tissue is reduced or even been interrupted, energy substances such as ATP and glucose that maintain normal cell metabolism are insufficient. After the ischemic stress, cell death in the ischemic region wrought under intracellular ion homeostasis, excitotoxicity, aseptic inflammation, apoptosis, tissue regeneration disorders and other pathological processes, and exacerbates neurological deficits (Fugate, 2017; McIntyre and Goldsmith, 2015; Reijmer, van Veluw, and Greenberg, 2016; Yuan, Zhang, Zheng, and Chen, 2015) . Stroke also alters systemic immunity except local inflammatory immune responses in the brain (Santos Samary et al., 2016) . Therefore, it is of urgently to elucidate the precise pathological mechanism of ischemic brain injury and propose a new therapy for non-pharmacological of stroke.
Microglia is permanent mononuclear macrophages that are involved in the innate immunity of the brain around neurons, astrocytes, and oligodendrocytes. The morphology of the microglia and the expressed protein are heterogeneous, so that different responses can be made in different environments (Kanazawa, Ninomiya, Hatakeyama, Takahashi, and Shimohata, 2017; Orihuela, McPherson, and Harry, 2016) . In the resting state, the intrinsic microglia continuously exert the function of immune-surveillance, and maintains the stability of the central nervous system by regulated synapses, impulses of neurons, and removal of cell debris. Activation of canonical M1 and alternative M2 macrophages is commonly reported in peripheral inflammation, but recent studies have found that microglia had similar activation processes in ischemic stroke (Kanazawa, Ninomiya, Hatakeyama, Takahashi, and Shimohata, 2017; Ma, Wang, Wang, and Yang, 2017) . Studies have found that M1 microglia has specific cell surface markers such as CD16, CD3, FcγR and inducible nitric oxide synthase. These markers are importantly involved in various functions such as cytotoxicity, superoxide production, and cytokine secretion. Conversely, alternative activated M2 microglia secrete a variety of anti-inflammatory factors such as IL-4, IL-10 and tumor necrosis factor-β, which show a great significance for promoting brain repair and neuronal regeneration (Qin et al., 2017; Walker and Lue, 2015) . In acute ischemic phase, microglia are activated and then polarized to M2 and this phenomenon is particularly evident in areas of injury around ischemic foci. Studies have shown that the addition of M1 microglia to cell culture media can aggravate neuronal death induced and HPC + MCO groups (n = 6). Data showed as mean values ± SD, *P < 0.05 was considered significant, n.s., not significant. by oxygen-glucose deprivation, whereas the addition of M2 microglia inhibits oxygen deprivation.
HPC (Hypoxic Preconditioning) refers to the administration of a certain intensity and previous exposure hypoxia before stress, which potentially enhance body's tolerance to subsequent severe hypoxia and ischemia. Recent studies have bolstered that pre-temporary or mild hypoxia activated the endogenous protective mechanism. HPC has the effect of alleviating hypoxic brain injury in neonatal rats and exerting neuroprotection (Parmar and Jones, 2015) . The possible mechanism may be that HPC mobilizes the endogenous protective mechanism of the body, and act as an active adaptive response of the body to oxidative stress, inflammatory response, apoptosis, and excitotoxicity caused by ischemia and hypoxia (Baillieul et al., 2017) .
In this study, we determined that HPC effectively alleviate middle cerebral artery occlusion (MCAO)-induced cerebral infarction. We verified the effects of MCAO on peripheral immune cell composition and found that MCAO effectively induces microglial activation. Finally, HPC changed MCAO-induced polarization of M1 microglia. Our results deepen the understanding of the molecular mechanisms of HPC prevention of stroke.
Results

HPC reduced infarct volume in ischemic rats
It has been reported that hypoxic preconditioning has a protective effect on hypoxic and ischemic brain damage. To clarify the effect of hypoxic preconditioning on MCAO, we first constructed a rat model of MCAO and hypoxic preconditioning. The Longa and NDSS methods were used to assess the extent of neurological deficits in animals, respectively. The results showed that MCAO significantly caused the occurrence of neurological deficit symptoms (P < 0.05). Separate hypoxic preconditioning did not significantly alter animal neurological functions and cognitions (P > 0.05). In addition, HPC significantly attenuated the loss of neurological functions caused by MCAO, whether it was assessed using Longa method or NDSS method (P < 0.05) ( Fig. 1A and B) . TTC staining of brain sections was further used to assess cerebral infarct size. No formation of cerebral infarction was observed in both the sham and HPC group. After 24 h of occlusion of the middle cerebral artery, a significant cerebral infarction area was observed in the MCAO group. However, the cerebral infarction area was relieved by HPC treatment (Fig. 1C and D) . Similarly, there were significant differences between MCAO group and MCAO group treated with HPC (P < 0.05).
Effect of HPC on microglia
To further explore the potential causes of HPC to alleviate MCAO cerebral infarction. Fig. 2A-B) . We then examined whether glial cells play a protective role in brain neurons under hypoxic conditions. The results showed that HPC significantly increased the expression levels of Iba1 and CNPase. The level of Iba1 was 4 times higher than that of the sham group and further increased with MCAO treatment (Fig. 2C-D) . It is suggested that microglia are potentially induced by HPC and participate in the MCAO process. Therefore, CD18, F4/80 and CD68, which are related to microglia activation, were further detected. HPC remarkably affected activation of microglia and was enhanced by MCAO treatment (Fig. 2E ). It indicated that microglia were strongly activated under HPC treatment and participated in subsequent MCAO process. After HPC treatment, it has a protective effect on apoptosis induced by MCAO, and the apoptosis level was reduced. Moreover, the results showed that apoptosis sharply increased between 24 and 72 h after MCAO treatment, whereas apoptosis significantly decreased after HPC treatment ( Fig. 2F-G ).
Effect of HPC on M1 to M2 transformation in microglia
The activation of microglia and its conversion of phenotypes play a key role in the inflammatory response and self-healing of neuronal damage in brain tissues. ELISA was used to detect chemokine levels in the infarcted cortex of rats. The results demonstrated that HPC strongly promotes the expression of IL-10 and TGF-β, and this trend was maintained after MCAO treatment. In addition, HPC reduced MCAOinduced upregulation of TNF-α and IL-6 expression (Fig. 3A) . It indicated that HPC promotes M2 activation of microglia. We examined the expression levels of M1 and M2 specific markers in microglia. We found that HPC promoted the expression of the M2 marker genes (Arg1, Ym1/2, IGF-1 and CD206). Conversely, MCAO significantly promoted the expression of the M1 marker genes (CD16, CCL3 and iNOS), and this result was changed by HPC (Fig. 3B ). Morphological analysis of Iba1 staining showed HPC induced microglia activation. The number of microglial bulges decreased or disappeared, and the morphology of microglia was round or amoebic with an increase in the number of microglia at the ischemic edge ( Fig. 3C-D ). Moreover, the expression level of BDNF, NGF, bFGF, Synapsin-1, PSD-95, SDF-1 was enhanced, alleviated nerve injury, and improved nerve growth and occurrence after HPC treatment. In addition, HPC up-regulated the expression of glucose transporters (GLUT) 1 and 3, increased the expression of VEGF and EPO, promoted the angiogenesis, and recovered the nerve function ( Fig. 3E-G) . Sum up, these results indicate that HPC affected MCAOinduced M1 polarization. The transformation of M1 to M2 reduced inflammatory levels and played a protective role on nerve injury.
Discussion
The central nervous system has an inherently high rate of oxygen consumption that lead to highly sensitive to oxygen concentrations for brain. There is a related adaptation and regulation mechanism of oxygen deficiency in animals' brain, the organism will redistribute the amount of systemic oxygen consumption rate to reducing central nervous system damage caused by hypoxia (Lutz, 1992 ). An theory of "acquired tolerance of tissue-cells to hypoxia" was thought to be developed through evolution (Li et al., 2017) . Although ability body for adapting to hypoxia has been extensively investigated, the time course and severity of hypoxia in these settings dramatically varied form pathological processes. Therefore, the adaptative response might not be identical. The occurrence of complex pathophysiological process may maintain hours or even days. Macrophages would enter the brain within 24 h and influx of lymphocytes usually occurred within 2-3 days after stroke outbreak (Santos Samary et al., 2016) . The processes of cellular death typically appeared 2-3 days in rodent models after ischemia and infarction. the neuron experienced a transient insult, and then degraded its nucleus and initiated a self-destruct sequence that happened days later during the process of apoptosis, (Smith, 2004) .
Previous studies showed that brain injury was significantly relieved and long-term cognitive function was greatly ameliorated after acclimated hypoxia for 3 h (Gustavsson, Anderson, Mallard, and Hagberg, 2005) . HPC prevents white matter injury caused by hypoxia-ischemia directly or the maturation of oligodendrocyte progenitor cells substituted the damaged myelin (Suryana and Jones, 2014) . HPC was also found to be protective against ischemic injury in cultured human brain endothelial cells, and drug inhibition of endothelial sphingosine kinase upregulation abrogated the neuroprotection afforded by hypoxic preconditioning against transient MCAO (Wacker, Park, and Gidday, 2009; Zhang, Park, and Gidday, 2007) . Although the mechanism of neuroprotection by hypoxic preconditioning remains elusive, glutamate receptors, NMDA receptors or ATP-dependent potassium channels appear to be involved in this process (Lee et al., 2015) . In Fig. 1C , the results clarified that HPC significantly attenuates MCAO-induced cerebral neurological impairment and infarction in rats. We herein confirmed the protective effect of HPC on ischemic brain injury by rat behavioral, cognitive scores and TTC staining. Interestingly, oligodendrocytes were activated and further maturation was not observed (data did not shown). In contrast, activation of HPC and ischemic brain microglia is evident. Microglia cells are resident immune cells in the brain that actively monitor the surrounding microenvironment and participate in the inflammatory response caused by acute brain injury (Morris, Clark, Zinn, and Vissel, 2013; Perry, Nicoll, and Holmes, 2010) . In the process of central nervous system inflammation, microglia cells have the ability to polarize to the M1 or M2 phenotype, including the ability to exhibit different cell morphology and phagocytic capacity. In a variety of models of brain injury, most of the microglia recruited at the injury sites expressed M2 signature genes, while after one week of injury, the expression of M1 signature genes in microglia cells peaked (Zhang et al., 2018; Davalos et al., 2005; Hu et al., 2012; Wang et al., 2013) . Under hypoxic conditions, microglia cells require energy expenditure mediating inflammatory cytokine production and cytoskeletal remodeling in an ATP-dependent manner (Gimeno-Bayon, Lopez-Lopez, Rodriguez, and Mahy, 2014; Masuda, Croom, Hida, and Kirov, 2011) . Thus, microglia cells exhibit susceptibility to ATP insufficient which caused by hypoxia. The activation of microglia into the M2 phenotype (SG et al., 2014 ) is more favorable for the regeneration of the central nervous system than M1 phenotype (Wang et al., 2018b) . The secretion of destructive factors by M1 microglia has also been shown to prevent nerve regeneration and aggravate long-term nerve damage (Ekdahl, Claasen, Bonde, Kokaia, and Lindvall, 2003) . Chronic treatment with minocycline, a selective inhibitor of M1 microglia can alleviate central nervous system injury, although this kind of treatment initially inhibits M1 microglia's ability to phagocytose and clear cell debris (Kim et al., 2009) . We examined the transformation in microglia phenotypes around the cerebral infarction after HPC treatment, and found that HPC significantly promoted the polarization of microglia to M2 phenotype and alleviate inflammation caused by MCAO. This is consistent with the results in other brain injury models.
In conclusion, our study demonstrated that HPC significantly attenuates ischemia-induced central nervous system injury by inducing microglia M2 phenotype polarization rather than peripheral immune cells. At present, there are few methods for clinical treatment of ischemic stroke, and t-PA (tissue plasminogen activator) is the only therapeutic drug with side effects (Parker and Ali, 2015) . However, hypoxia preconditioning (HPC) can increase cell hypoxia tolerance, promote synthesis of a variety of cytokines, maintain cell activity and tissue repair (Wang et al., 2018a; Li et al., 2017) . Therefore, this study helps to increasing the comprehension of the protective mechanism of HPC in the central nervous system and the treatment of stroke.
Materials and methods
Animal
Male Sprague-Dawley rats (280-300 g) were purchased from Charles River Animal Center (Beijing, China). Animal projects for our studies are in accordance with the Institutional Animal Care and Use Committee of Qinghai University. Animals were individually housed and maintained on a 12 h light and dark cycle with free access to water and standard rat chow, and temperature-and humidity-controlled. All manipulations were made to minimize animal suffering and reduce the number of animals used. Rats were grouped of sham operation, HPC, MCAO or co-treatment with HPC and MCAO.
Hypoxic preconditioning
Before the start of HPC, rats were acclimated to the custom-made Plexiglas chambers (one rat per chamber, gas flow through chamber = 4 L/min) under normoxic conditions. We used the chamber simulated the environment of altitude 5000 m. Oxygen pressure: 42 mmHg; barometric pressure: 0.53x10 5 Pa. The process lasts for 3 h at a time, and then the normoxic conditions were restored. The repeatedly manipulation proceed 14 days. All the animals were allowed free access to food and water during HPC. As for the conditions of hypoxia pretreatment, we simulated the high-altitude environment with intermittent hypoxia and made some improvement based on the regional characteristics and the high-altitude region (Qiao et al., 2015) .
Rat middle cerebral artery occlusion (MCAO)
MCAO was induced with the unilateral carotid insertion of a surgical filament method (Chiang, Messing, and Chou, 2011) . Briefly, the animals were anesthetized with sodium pentobarbital (200 mg/kg). MCAO preparatory procedure was carried out on the left side of the rat. A midline incision 1 cm was made in the neck. And identify common carotid artery (CCA) and external carotid artery (ECA) and internal carotid artery (ICA). Isolate the CCA carefully and avoid damaging the nearby vagus nerve and trachea, which could increase infarct size and decrease viability. Loosely tie silk sutures around proximal and distal ends of CCA, respectively. And then ligated the proximal of CCA, the distal end of CCA was clamped with an artery clamp. Then a "V" shaped small hole was cut in the middle of the two lines, and the filament was inserted. The direction was towards the distal end of CCA, and when mild resistance was felt, it was stopped and ligated the suture. After occlusion both common carotid arteries for 10 min, rats that had lost righting reflex within 1 min and whose pupils were dilated were selected for experiments. Rectal temperature was maintained at 37-38°C throughout the procedure. Sham-operated rats were performed with the same surgical procedures except that the arteries were not occluded. Previous studies showed that ischemia injury reached its maximum at 24 h in rats, with the ratio of the infracted brain area to the total brain section was 0.18 .
Neurological evaluation
Rat neurological deficits were assessed, although at this time point the neurological deficit and infarct volume are fully developed, ischemic penumbra or peri-infarct region exits more apparently and the inflammatory molecular changes in this region. Neurological deficits were scored according to Longa or neurological disability status scale (NDSS) (Longa, Weinstein, Carlson, and Cummins, 1989; Rodriguez, Santiago-Mejia, Gomez, and San-Juan, 2005) . NDSS has 10 progressive steps beyond 0 (normal), extending to status 10 (death). Accordingly, Longa has 5 progressive steps beyond 0 (normal), extending to status 5 (loss of consciousness). In all cases, where criteria for the precise grade were not met, the nearest appropriate number was utilized.
Flow cytometry
The blood sample 100 µl was added into FACS tubes and then add 10 µl antibody of CD3-FITC, CD8a-PE、CD4-PECY5, CD45-FITC、CD161-PE. The samples incubated 15-20 min after homogenization without light. Erythrocyte lysate 500 µl added into the above sample, and then incubated 10 min in dark place after mixed. Centrifuge at 15 min 1500g/min after homogenization again. Discard the supernatant, PBS was used to homogenization, after that, samples subjected to centrifuge 5 min 1500g/min. Discard the supernatant, preparing the sample use PBS. Detect the sample within 2 h with instruments. Navios tetra software was used for analysis of flow cytometry.
TTC staining for evaluated damage of ischemic
Double blind measurements of the infarct volume and edema were taken, once finished the evaluation of neurological deficits. Rats were euthanized, and the brain was quickly removed and cut into 1.5 mm thick coronal sections. Brain sections were incubated for 20 min in a solution of 0.5% 2, 3, 5-triphenyltetrazolium chloride (TTC) in 0.01 M phosphate buffered saline at 37℃, and then the slices were scanned into a computer. Images were analyzed using Image Pro Plus1 6.0 (Media Cybernetics, Silver Spring, MD) according to the ischemic area evaluation procedure .
Histological examination
Immunohistochemistry was performed to identify activated colloidal cell using the marker Iba1, CNP-ase and GFAP respectively. Briefly, sections were thawed and treated with 3% hydrogen peroxide for 30 min. After blocking in 4% skim milk containing 0.4% Triton X-100 for 30 min at room temperature, the sections were incubated overnight at 4℃ with primary antibodies of Iba1 (1:200, ab178846, Abcam, UK), GFAP (1:200, ab7260, Abcam, UK), GNP-ase (1:200, ab227218, Abcam, UK). Sections were then washed several times in PBS and incubated with a biotinylated secondary antibody and then treated using an avidin-biotin complex kit (ABC kit; Vector Laboratories. Burlingame, California). Finally, the labeling was detected by treatment with 0.01% hydrogen peroxide and 0.05% 3, 3′-diaminobenzidine (DAB; Sigma, St. Louis, MO, USA). The DAB reaction was stopped by rinsing tissues in PBS. Labeled tissue sections were then mounted and analyzed under a bright-field microscope.
Chemokine levels and growth factors detection in the infarcted cortex
An appropriate amount of ischemic brain tissue was obtained and phosphate-buffered saline (PBS) was added. The tissues were homogenized and then centrifuged at 10,000g for 10 min, supernatants were collected. ELISA kits for rat tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10, tumor growth factor (TGF)-ß, brain derived neurotrophic factor (BDNF), nerve growth factor (NGF), basic fibroblast growth factor (bFGF) (Abcam) were used for the experiments. The absorbance at 450 nm was measured. Standard curves were drawn and used to calculate the concentrations of TNF-α, IL-6, IL-10, TGF-ß, BDNF, NGF and bFGF in the testing samples. All the protocols were carried out according to the manufactures' instructions.
The reaction of qRT-PCR
Fresh tissues were collected and total RNA was extracted from tissues using trizol reagent and miRNeasy mini kit (Invitrogen). The cDNA was synthesized by reverse transcription using SuperScript II (Invitrogen). Quantitative PCR was performed in 20 μl reaction system containing specific primers, cDNA and SYBR Premix EX Taq (Takara, China). The primer information is as follows. The levels of mRNA were normalized to GAPDH. 2 −ΔΔCt method was used to analyze the data.
Primer sequences are shown in Table 1 .
Western blot
The tissues were lysed with RIPA for 30 min on ice, centrifuged at 12,000g for 10 min at 4℃, and the supernatant was collected. The protein concentration was determined by BCA method. Equal concentration of total proteins were subjected by SDS-PAGE and transferred onto PVDF membrane. Then the membrane was blocked with PBST containing 5% BSA for 1 h at room temperature, and incubated with primary antibodies (Bcl-2, Bax, Synapsin-1, PSD 95, SDF-1) overnight at 4℃. Then HRP-labeled secondary antibody was added to the membrane at room temperature for 1 h. Finally, the signal bands for the membrane were detected using the enhanced chemiluminescence kit. Grayscale analysis was performed.
Statistics Statistical
Analyses were performed using SAS v8.0 (SAS Institute, Cary, NC). Data were analyzed using one-way ANOVA procedure. Comparisons among individual means were made by Fisher's least significant difference (LSD). Data are presented as mean ± SEM. *P < 0.05 was considered to be significant. 
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